Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A preparation method of anticoagulant fibrinolytic nanofiber material

A nanofiber, anticoagulant technology, applied in the field of biomedical engineering, can solve problems such as limiting the application of heparin, and achieve the effect of improving the binding rate, anti-inflammatory, antipyretic and analgesic, and preventing thrombosis.

Active Publication Date: 2021-10-12
广州大鱼创福科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the anticoagulant activity of heparin, a large amount of heparin will cause side effects such as bleeding and induction of thrombocytopenia, which greatly limits the clinical application of heparin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0025] The invention provides a preparation method of anticoagulant fibrinolytic nanofiber material, comprising the following steps:

[0026] S1: Dissolve chitosan, polyethylene oxide and acetylsalicylic acid in an acetic acid solution, and stir to obtain a core spinning solution;

[0027] S2: Dissolve chitosan, polyethylene oxide and lumbrokinase in acetic acid solution, and stir to obtain chitin spinning solution;

[0028] S3: using the core spinning solution as the core and the chitin spinning solution as the shell to perform coaxial electrospinning to obtain acetylsalicylic acid / lumbrokinase nanofibers;

[0029] S4: washing the acetylsalicylic acid / lumbrokinase nanofibers with DMEM medium to a pH of 7.2, and then lyophilized and activated by a plasma processor to obtain activated nanofibers;

[0030] S5: soaking the activated nanofibers in DMEM medium containing low molecular weight heparin sodium, performing negative pressure flash explosion, performing grafting reaction...

Embodiment 1

[0044] S1. The viscosity average molecular weight of 0.5g is 5.0×10 5 , Chitosan with 80% degree of deacetylation, 1.5g average molecular weight 1.0×10 6 The polyethylene oxide and 0.8g of acetylsalicylic acid were completely dissolved in 100ml of 90% (v / v) acetic acid solution, and after stirring evenly, the core spinning solution was obtained;

[0045] S2, the viscosity average molecular weight of 0.5g is 5.0×10 5 , Chitosan with 80% degree of deacetylation, 1.5g average molecular weight 1.0×10 6 The polyethylene oxide and 0.05g of lumbrokinase with an enzyme activity of 8U / mg were completely dissolved in 100ml of 90% (v / v) acetic acid solution, and after stirring evenly, the chitin spinning solution was obtained;

[0046] S3. Use the core spinning solution as the core and the chitin spinning solution as the shell to perform coaxial electrospinning, and the needle specification is a coaxial needle; the electrospinning conditions are, the voltage is 15KV, the distance is 12...

Embodiment 2

[0050] S1. The viscosity average molecular weight of 0.5g is 5.0×10 5 , Chitosan with 80% degree of deacetylation, 0.5g average molecular weight 1.0×10 6 The polyethylene oxide and 0.5g of acetylsalicylic acid were completely dissolved in 100ml of 90% (v / v) acetic acid solution, and after stirring evenly, the core spinning solution was obtained;

[0051] S2, the viscosity average molecular weight of 0.5g is 5.0×10 5 , Chitosan with 80% degree of deacetylation, 0.5g average molecular weight 1.0×10 6 The polyethylene oxide and 0.01g of lumbrokinase with an enzyme activity of 5U / mg were completely dissolved in 100ml of 90% (v / v) acetic acid solution, and after stirring evenly, the chitin spinning solution was obtained;

[0052] S3. Use the core spinning solution as the core and the chitin spinning solution as the shell to perform coaxial electrospinning, and the needle specification is a coaxial needle; the electrospinning conditions are, the voltage is 12KV, the distance is 7c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a preparation method of anticoagulant fibrinolytic nanofiber material, which comprises (1) completely dissolving chitosan, polyethylene oxide and acetylsalicylic acid in 90% acetic acid solution, and stirring evenly to obtain core fiber silk liquid; (2) fully dissolving chitosan, polyoxyethylene and lumbrokinase in 90% acetic acid solution, stirring evenly to obtain chitin spinning solution; (3) adopting coaxial electrospinning to obtain acetylsalicylic acid Acid / lumbrokinase nanofibers; (3) acetylsalicylic acid / lumbrokinase nanofibers were washed to neutral with DMEM medium, and then activated by plasma processor after lyophilization; (4) activated nanofibers were soaked in low Negative-pressure flash explosion in DMEM medium of sodium heparin, followed by grafting reaction, centrifugation and freeze-drying. The anticoagulant fibrinolytic nanofiber provided by the invention can better prevent thrombus formation.

Description

technical field [0001] The invention relates to the field of biomedical engineering, in particular to a preparation method of an anticoagulant fibrinolytic nanofiber material. Background technique [0002] Anticoagulation and fibrinolysis are the main treatment methods for cardiovascular and cerebrovascular embolism, and heparin is a commonly used anticoagulant in the treatment of cardiovascular and cerebrovascular embolism. Heparin is a mucopolysaccharide formed by alternating 1→4 glycosidic linkages of hexuronic acid (L-iduronic acid, D-glucuronic acid) and D-glucosamine sulfate, linear with repeating units of hexasaccharides or octasaccharides. Chain structure, its molecular weight is between 3000-37000Da, used as anticoagulant and antithrombotic agent in medicine. In addition, heparin also has various biological functions such as anti-inflammatory, anti-allergic, anti-viral, anti-cancer, and blood lipid regulation. However, due to the anticoagulant activity of heparin,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): D01F8/18D01F8/16D01F1/10A61L33/10A61L33/04A61L33/16
CPCA61L33/0011A61L33/0047A61L33/04A61L33/08A61L2300/216A61L2300/232A61L2300/254A61L2300/42D01F1/10D01F8/16D01F8/18C08L5/10
Inventor 汤佳鹏葛彦刘希文朱俐
Owner 广州大鱼创福科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com